Abstract: A method may include: hydropyrolyzing a bio feedstock in a hydropyrolysis unit to produce at least a hydropyrolysis oil; introducing at least a portion of the hydropyrolysis oil with a hydrocarbon co-feed into a fluidized catalytic cracking unit; and cracking the hydropyrolysis oil in the fluidized catalytic cracking unit to produce at least fuel range hydrocarbons.

Abstract: The present application discloses a method and a model for controlling an energy storage system for rail transit, a device, and a storage medium. The method includes: determining an offline charging-discharging action according to a state of an energy storage system based on an offline algorithm; determining an online charging-discharging action according to the state of the energy storage system based on a deep reinforcement learning algorithm; acquiring a fusion ratio of the offline charging-discharging action to the online charging-discharging action according to a communication delay amount and a delay degree; and fusing the offline charging-discharging action and the online charging-discharging action according to the fusion ratio and outputting a fusion result to the energy storage system.

Abstract: The present disclosure discloses a novel strain of Glutamicibacter, derived from insects, which efficiently degrades bifenthrin, belonging to the field of microbial strains. The Glutamicibacter CCTCC NO: M20221445 of the present disclosure was isolated from the intestinal tract of bifenthrin-resistant Ectropis grisescens Warren larvae. It exhibits unique genomic characteristics, growth and phenotypic traits, physiological and biochemical characteristics, as well as the ability to utilize and degrade bifenthrin efficiently. Specifically, it can effectively degrade bifenthrin. Based on phenotypic features, physiological and biochemical characteristics, chemical composition, and molecular biology-based polyphasic classification, Glutamicibacter CCTCC NO: M20221445 is identified as a new species. This bacterium possesses the capability to efficiently degrade bifenthrin, laying the foundation for biological control of E. grisecens and offering new microbial resources to address pesticide residue problems.

Abstract: A control method, device, apparatus and storage medium for a supercapacitor energy storage device is provided, where the method includes: collecting life characterization parameters of the supercapacitor energy storage device and performing life evaluation to obtain a life evaluation result, inputting the life evaluation result into a constructed fuzzy rule base, and outputting a constraint condition adjustment parameter; obtaining a constraint condition according to the constraint condition adjustment parameter, and optimizing control parameters using a genetic algorithm in conjunction with an optimized objective function to obtain first control parameters; and controlling charging and discharging currents of the supercapacitor energy storage device using a droop control method according to the first control parameters.

Abstract: An effective capacity estimation method and system for super capacitor energy storage systems are provided. The method includes: establishing a nonlinear electrical model of supercapacitor cell and an equivalent electrical model of a supercapacitor system; obtaining the first test data by charging the supercapacitor cell; based on the first test data, setting the initial value of parameters of the nonlinear electrical model of the supercapacitor cell by a preset algorithm; using a least-square method to identify the parameters of the nonlinear electrical model of the supercapacitor cell; obtaining electrical parameters of the equivalent electrical model of the supercapacitor system except the connection resistance parameters, carrying out a charging test of the supercapacitor system to obtain the connection resistance parameters, and estimating an effective capacity of the supercapacitor energy storage system based on the equivalent electrical model of the supercapacitor system after parameter identification.

Abstract: The present invention relates to a mutant G-CSF fusion protein. The mutant G-CSF fusion protein is a fusion protein having the activity of stimulating the proliferation of neutrophilic granulocytes, and having a basic structure of G-CSF/carrier protein or carrier protein/G-CSF; wherein the G-CSF moiety comprises multipoint substitutions thus resulting in changes in biological activity and binding affinity. Compared with existing products, the mutant G-CSF fusion protein in the present invention has longer half-life and higher biological activity. Administration of the pharmaceutical preparation containing this mutant G-CSF fusion protein could be used in the treating neutropenia.

Abstract: The present invention relates to a mutant G-CSF fusion protein. The mutant G-CSF fusion protein is a fusion protein having the activity of stimulating the proliferation of neutrophilic granulocytes, and having a basic structure of G-CSF/carrier protein or carrier protein/G-CSF; wherein the G-CSF moiety comprises multipoint substitutions thus resulting in changes in biological activity and binding affinity. Compared with existing products, the mutant G-CSF fusion protein in the present invention has longer half-life and higher biological activity. Administration of the pharmaceutical preparation containing this mutant G-CSF fusion protein could be used in the treating neutropenia.